John Treml
6Patents
3h-index
4Co-inventors
46Inventor score
Filing activity: May 8, 2001 → Feb 15, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7387776B2 | Human monoclonal antibodies against CD30 | Emerging Cross-Sectional Technologies | 28 | Expired |
| US7560534B2 | Molecular conjugates comprising human monoclonal antibodies to dendritic cells | Chemistry; Metallurgy | 20 | Expired |
| US7563876B2 | Human monoclonal antibodies to dendritic cells | Chemistry; Metallurgy | 9 | Expired |
| US8088377B2 | Human monoclonal antibodies against CD30 | Emerging Cross-Sectional Technologies | 2 | Active |
| US8142790B2 | Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells | Chemistry; Metallurgy | 2 | Active |
| US9095626B2 | Monoclonal antibodies to dendritic cells | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.